Harvard Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HBIO and other ETFs, options, and stocks.

About HBIO

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. 

CEO
James W. Green
CEOJames W. Green
Employees
355
Employees355
Headquarters
Holliston, Massachusetts
HeadquartersHolliston, Massachusetts
Founded
1901
Founded1901
Employees
355
Employees355

HBIO Key Statistics

Market cap
15.19M
Market cap15.19M
Price-Earnings ratio
-0.26
Price-Earnings ratio-0.26
Dividend yield
Dividend yield
Average volume
1.88M
Average volume1.88M
High today
$0.3554
High today$0.3554
Low today
$0.3323
Low today$0.3323
Open price
$0.35
Open price$0.35
Volume
421.87K
Volume421.87K
52 Week high
$3.60
52 Week high$3.60
52 Week low
$0.29
52 Week low$0.29

HBIO News

Simply Wall St 5d
Harvard Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Harvard Bioscience ( ) First Quarter 2025 Results Key Financial Results Revenue: US$21.8m (down 11% from 1Q 2024). Net loss: US$50.3m (loss widened by US$45....

Harvard Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
TipRanks 6d
Harvard Bioscience Earnings Call: Mixed Sentiments and Strategic Moves

Harvard Bioscience ((HBIO)) has held its Q1 earnings call. Read on for the main highlights of the call. Protect Your Portfolio Against Market Uncertainty The...

People also own

Based on the portfolios of people who own HBIO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.